Pith. sign in

REVIEW 3 major objections 6 minor 28 references

Refining Platelet Purification Methods: Enhancing Proteomics for Clinical Applications

T0 review · 3 major / 6 minor · reviewed 2026-08-07 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read LFQ-DIA finds 4,743 platelet proteins, topping DDA and TMT.

desk verdict The protocol tweak and three-way mass spec comparison are solid enough for peer review, but the age-related differential expression claim is statistically indistinguishable from noise and should not be published as-is. read the letter →

arxiv 2505.24394 v1 pith:OLG5R5NZ submitted 2025-05-30 q-bio.BM q-bio.GN

Vibecke Markhus , Katarina Fritz-Wallace , Olav Mjaavatten , Einar K. Kristoffersen , Dorota Goplen , Frode Selheim This is my paper
classification q-bio.BMq-bio.GN
keywords plateletproteomicsisolationdifferentialcentrifugationLFQ-DIAdata-independentacquisitionlabel-freequantificationTMTlabelingage-matchedcontrols
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper argues that a simple differential-centrifugation protocol refined to a ten-minute spin at 330 g produces platelet samples clean enough for clinical proteomics, and that among three mass-spectrometry workflows, label-free quantification with data-independent acquisition (LFQ-DIA) gives the broadest and most sensitive view of the platelet proteome. Using ten healthy donors, the authors report 4,743 proteins identified by LFQ-DIA, more than the 4,232 by TMT-DDA and 3,663 by LFQ-DDA, with 728 proteins unique to LFQ-DIA. They also report 53 proteins whose abundance differs between younger and older donors and use this to argue that platelet biomarker studies should match donors by age. A sympathetic reader would take this as a practical recommendation: use the refined isolation protocol and LFQ-DIA for platelet biomarker discovery, and control for age.

What carries the argument

The load-bearing object is the pipeline itself: a differential-centrifugation isolation protocol shortened to a 10-minute 330 g spin, followed by dilution and two further spins, that removes WBC and RBC contamination to below detection while preserving platelet yield, and then a parallel LC-MS/MS comparison of three workflows on the same donor samples: LFQ-DIA, LFQ-DDA, and TMT-DDA. The comparison is carried by protein identification counts after a 70% valid-value filter and a 1% FDR, with LFQ-DIA covering 4,743 proteins. A second component is the statistical machinery for the age comparison, a two-sample Welch t-test at p<0.01 applied to log2-transformed abundances, which yields the 53 candidate differential proteins.

What would settle it

Recompute the differential analysis on the same or a larger donor set while applying a Benjamini-Hochberg false-discovery-rate correction at 5%; if none or only a few of the 53 proteins survive, the age-related proteome claim as stated is not supported.

Watch

Extended reading notes

Core claim

The paper's central claim is that its optimized platelet isolation protocol—whole blood centrifuged at 330 g for 10 minutes, followed by dilution and two further washing spins—reduces white and red blood cell contamination below detection while preserving platelet yield, and that LFQ-DIA is the best of the three tested mass-spectrometry methods for platelet proteomics in terms of coverage and sensitivity. The results section reports LFQ-DIA identified 4,743 proteins including 728 unique to it, versus 4,232 for TMT-DDA and 3,663 for LFQ-DDA, with 3,092 proteins common to all three methods. In the same sample set, the authors identify 53 proteins differentially expressed between younger donors (median age 53 years) and older donors (median age 70 years), with MGMT higher in older donors and PON3 and FBLN1 higher in younger donors. The authors conclude that LFQ-DIA is the most suitable approach for comprehensive platelet protein analysis and that age matching is necessary in platelet-based biomarker studies.

Load-bearing premise

The age-related conclusion depends on treating proteins with a two-sample Welch t-test p<0.01 as genuinely different without correcting for the roughly four thousand proteins being tested; with about 40 expected false positives, the 53 reported proteins could largely be noise.

Editorial extensions

If this is right

  • Clinical laboratories can adopt the 10-minute 330 g centrifugation protocol to prepare high-purity platelet samples with lower blood volume and shorter processing time.
  • LFQ-DIA should be preferred over LFQ-DDA and TMT-DDA for clinical platelet proteomics when reproducibility, coverage, and minimal missing data are priorities.
  • The 53 age-related proteins, if confirmed, imply that platelet biomarker candidate lists from unmatched cohorts may be partly driven by donor age rather than disease.
  • A well-designed platelet biomarker study should recruit age-matched controls or model age as a covariate.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • We infer that the 4,743-protein DIA count, gathered from only ten donors with a 70% valid-value filter, is an upper bound for a routine clinical cohort; larger cohorts with stricter filters would likely see a lower reproducible count.
  • We infer that the age effect should be re-tested with false-discovery-rate correction; at p<0.01 across roughly 4,000 proteins, about 40 false positives are expected by chance, so the true number of age-associated proteins may be smaller than 53.
  • We infer that the apparent DIA coverage advantage may partly reflect the longer 195-minute LC gradient and FAIMS settings used for DIA rather than the acquisition mode alone; a matched-gradient comparison would separate protocol effects from method effects.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 6 minor

Summary. The manuscript optimizes a differential-centrifugation protocol for isolating human platelets and compares three mass-spectrometry workflows (LFQ-DIA, LFQ-DDA, and TMT-DDA) on samples from ten healthy donors. The authors report that LFQ-DIA identifies the most platelet proteins (4,743) and therefore recommend it for clinical platelet proteomics. They also report 53 proteins differentially expressed between younger and older donors and conclude that platelet biomarker studies should age-match controls. The raw proteomics data are deposited in ProteomeXchange (PXD058404).

Significance. If the comparative results are reliable, the practical recommendations—an inexpensive, high-purity isolation protocol and LFQ-DIA as the preferred acquisition strategy—would be useful for the clinical proteomics community. The manuscript is an empirical comparison rather than a derivational study, and it benefits from explicit instrument settings, deposited raw data, and a clear workflow description. However, the two headline conclusions are currently supported more strongly than the evidence warrants: the age-related differential-expression result is statistically fragile, and the method comparison is partly confounded by differing acquisition and analysis parameters.

major comments (3)
  1. [Data Analysis and Results (age-related differences)] The age-related differential expression claim is not supported by the reported statistics. With roughly 4,700 proteins tested and a Welch t-test at p<0.01, the expected number of false positives under the global null is about 47; the paper reports 53, a trivial excess that falls within Poisson sampling noise. No multiple-testing correction is described for this test. Since the abstract and conclusion use this result to argue that age-matching is necessary in platelet biomarker studies, this is a load-bearing issue. The authors should either apply a multiple-testing correction (e.g., Benjamini-Hochberg or permutation-based FDR) and show that the 53 proteins survive, or explicitly reframe the age comparison as exploratory and hypothesis-generating.
  2. [Materials and Methods / LC-MS/MS analysis; Results (method comparison)] The comparison of LFQ-DIA, LFQ-DDA, and TMT-DDA is not fully controlled: DIA data were processed with Spectronaut while DDA and TMT data were processed with Proteome Discoverer; the DDA and DIA runs used different FAIMS compensation voltages, different gradient lengths (195 min for DDA/DIA versus 105 min for TMT), and different sample amounts (0.5 µg for DDA versus 0.8 µg for DIA); TMT additionally involved fractionation and MS3 acquisition. These differences are described in the supplement, but the conclusion that 'LFQ-DIA demonstrated superior protein coverage and sensitivity' is an observation about these particular settings, not a general property of the three methods. The authors should either justify that the settings are standard and comparable, or temper the conclusion to state that LFQ-DIA performed best under the specific conditions tested.
  3. [Results, Platelet Purity and Contamination Control] The claim of 'at least 99.99% WBC purity' is not directly measured. The data show that WBC and RBC counts were below the detection limit of the Sysmex XN-9100 after 10 minutes of centrifugation, but the detection limit is not reported. Inferring a specific purity percentage from a below-detection observation is an extrapolation. Please report the detection limits and restate the result as an upper bound (e.g., 'below the detection limit of the counter') rather than a measured purity value.
minor comments (6)
  1. [Abstract] The sentence 'age-related differences in platelet protein composition were observed' should be qualified as 'exploratory' given the lack of multiple-testing correction, to avoid overstating the finding.
  2. [Materials and Methods, Platelet isolation] The text uses informal notation such as '1xPBS' (should be '1×PBS') and 'Gu-HCL' (should be 'Gu-HCl' or 'guanidine hydrochloride').
  3. [Materials and Methods, Platelet isolation] The phrase 'vortexed (RPM 400)' is ambiguous; specify the shaker speed in rpm or the vortexing duration.
  4. [Data Analysis] The decimal comma in 'p<0,01' is inconsistent with the rest of the manuscript and should be 'p<0.01'.
  5. [Introduction / Results] The text refers to 'three different data-independent methodologies' but DDA is data-dependent acquisition; this should say 'three different MS-based proteomic approaches.'
  6. [Conclusion] The phrase 'cost-effective and reliable' is not quantified; a brief cost or time comparison with alternative protocols would strengthen the claim.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: the paper is an empirical method comparison; the age-related claim is statistically fragile but not circular.

full rationale

This paper reports an empirical method comparison and a discovery-oriented group comparison; there is no derivation chain in which a fitted parameter is renamed as a prediction. The LFQ-DIA-versus-LFQ-DDA-versus-TMT-DDA conclusion rests on measured protein identification counts (4,743 vs. 3,663 vs. 4,232), not on any equation presupposing DIA superiority. The centrifugation-time optimization is also a direct measurement of yields, purities, and contamination levels. The age-related claim is produced by a Welch t-test at p<0.01 on roughly 4,700 proteins without multiple-testing correction, so the 53 reported hits are close to the number expected by chance; this makes the age-matching recommendation statistically fragile, but that is a validity and robustness concern, not circularity, because the test result does not define the hypothesis it is supposed to support. The only self-citation (ref. 23, Carrillo-Rodriguez, Selheim et al.) appears in the discussion supporting the general need for demographic matching and is accompanied by an independent citation (ref. 26); it is not load-bearing for any derived quantity. The comparison is also limited by different software and acquisition parameters across methods (Spectronaut for DIA, Proteome Discoverer for DDA/TMT), but that is an experimental-design fairness issue, not circular reasoning. No equation in the paper reduces to its own input by construction.

Assumptions & free parameters 3 free parameters · 3 assumptions · 0 invented entities

The reported protein counts and age-group differences depend on several hand-chosen thresholds (centrifugation time, 70% valid-value filter, p<0.01) and on domain assumptions about the cell counter and software defaults. No invented biological entities are introduced; the paper is purely methodological.

free parameters (3)
  • Centrifugation time at 330 g = 10 minutes
    Chosen from empirical comparison of 5, 7, and 10 minutes to maximize platelet yield and purity; not derived from first principles.
  • 70% valid value filter = 70%
    Applied in Perseus to retain proteins quantified in at least 7 of 10 donors; arbitrary threshold that affects reported protein counts.
  • Welch t-test p-value threshold = p<0.01
    Chosen for the age-group comparison; no multiple-testing correction is mentioned, which inflates the number of apparent hits.
assumptions (3)
  • domain assumption Platelet counts and contamination measured by Sysmex XN-9100 automated cell counter are accurate at low WBC and RBC levels.
    Purity claims rely on cell counter detection limits; no flow cytometry or microscopy verification is shown.
  • domain assumption The 10 healthy donors are representative of younger and older adult populations.
    Age-group comparison uses median 53 years vs 70 years with n=10 total; this is a small convenience sample.
  • domain assumption Protein identification by Spectronaut and Proteome Discoverer with default settings gives comparable quantitative accuracy across methods.
    Method comparison assumes the search engines and instrument settings do not bias the comparison in favor of DIA.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Refining Platelet Purification Methods: Enhancing Proteomics for Clinical Applications." pith.science (2026). https://pith.science/paper/OLG5R5NZ

@misc{pith2026250524394,
  author       = {Pith},
  title        = {Pith review of: Refining Platelet Purification Methods: Enhancing Proteomics for Clinical Applications},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/OLG5R5NZ}},
  note         = {Machine review of arXiv:2505.24394}
}
read the original abstract

Background: Platelet proteomics offers valuable insights for clinical research, yet isolating high-purity platelets remains a challenge. Current methods often lead to contamination or platelet loss, compromising data quality and reproducibility. Objectives: This study aimed to optimize a platelet isolation technique that yields high-purity samples with minimal loss and to identify the most effective mass spectrometry-based proteomic method for analyzing platelet proteins with optimal coverage and sensitivity. Methods: We refined an isolation protocol by adjusting centrifugation time to reduce blood volume requirements while preserving platelet yield and purity. Using this optimized method, we evaluated three proteomic approaches: Label-free Quantification with Data-Independent Acquisition (LFQ-DIA), Label-free Quantification with Data-Dependent Acquisition (LFQ-DDA), and Tandem Mass Tag labeling with DDA (TMT-DDA). Results: LFQ-DIA demonstrated superior protein coverage and sensitivity compared to LFQ-DDA and TMT-DDA. The refined isolation protocol effectively minimized contamination and platelet loss. Additionally, age-related differences in platelet protein composition were observed, highlighting the importance of using age-matched controls in biomarker discovery studies. Conclusions: The optimized platelet isolation protocol provides a cost-effective and reliable method for preparing high-purity samples for proteomics. LFQ-DIA is the most suitable approach for comprehensive platelet protein analysis. Age-related variation in platelet proteomes underscores the need for demographic matching in clinical proteomic research.

Figures

Figures reproduced from arXiv: 2505.24394 by the authors.

Figure 1
Figure 1. Schematic overview of the isolation of platelets process outlined in this protocol [PITH_FULL_IMAGE:figures/full_fig_p010_1.png] view at source ↗

Discussion (0). Sign in to comment.

Reference graph

Works this paper leans on

28 extracted references · 28 canonical work pages

  1. [1]

    Int J Mol Sci, 2020

    Gianazza, E., et al., Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics. Int J Mol Sci, 2020. 21(12)

    work page 2020

  2. [2]

    In 't Veld, S. and T. Wurdinger, Tumor-educated platelets. Blood, 2019. 133(22): p. 2359- 2364

    work page 2019

  3. [3]

    J Proteomics, 2018

    Sabrkhany, S., et al., Exploration of the platelet proteome in patients with early-stage cancer. J Proteomics, 2018. 177: p. 65-74

    work page 2018

  4. [4]

    Biomedicines, 2024

    Chaudhary, P.K., et al., The Perspectives of Platelet Proteomics in Health and Disease. Biomedicines, 2024. 12(3)

    work page 2024

  5. [5]

    Blood, 2012

    Burkhart, J.M., et al., The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood, 2012. 120(15): p. e73-82

    work page 2012

  6. [6]

    World J Biol Chem, 2021

    Al-Amrani, S., et al., Proteomics: Concepts and applications in human medicine. World J Biol Chem, 2021. 12(5): p. 57-69

    work page 2021

  7. [7]

    Simpson, and D.W

    Sparrow, R.L., R.J. Simpson, and D.W. Greening, Protocols for the Isolation of Platelets for Research and Contrast to Production of Platelet Concentrates for Transfusion. Methods Mol Biol, 2023. 2628: p. 3-18

    work page 2023

  8. [8]

    J Biol Chem, 2010

    Gambaryan, S., et al., Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem, 2010. 285(24): p. 18352-63

    work page 2010

Show all 28 references
  1. [9]

    Platelets, 2017

    Wrzyszcz, A., et al., An efficient method for isolation of representative and contamination- free population of blood platelets for proteomic studies. Platelets, 2017. 28(1): p. 43-53

    2017

  2. [10]

    Clin Proteomics, 2023

    Birhanu, A.G., Mass spectrometry-based proteomics as an emerging tool in clinical laboratories. Clin Proteomics, 2023. 20(1): p. 32

    2023

  3. [11]

    Clin Proteomics, 2024

    Wenk, D., et al., Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers. Clin Proteomics, 2024. 21(1): p. 6

    2024

  4. [12]

    J Mol Biol, 2021

    Fonseka, P., et al., FunRich enables enrichment analysis of OMICs datasets. J Mol Biol, 2021. 433(11): p. 166747

    2021

  5. [13]

    Acta Neurochir (Wien), 2024

    Ghimire, P., et al., MGMT methylation and its prognostic significance in inoperable IDH- wildtype glioblastoma: the MGMT-GBM study. Acta Neurochir (Wien), 2024. 166(1): p. 394

    2024

  6. [14]

    Nat Rev Cancer,

    Gerson, S.L., MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer,

  7. [15]

    Reichert, and S.P

    Levy, D., C.O. Reichert, and S.P. Bydlowski, Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview. Antioxidants (Basel), 2019. 8(5)

    2019

  8. [16]

    Diaz-Ricart, and W.S

    Godyna, S., M. Diaz-Ricart, and W.S. Argraves, Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood, 1996. 88(7): p. 2569-77

    1996

  9. [17]

    Repsold, L. and A.M. Joubert, Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders. Cells, 2021. 10(11)

    2021

  10. [18]

    Burnouf, T. and T.L. Walker, The multifaceted role of platelets in mediating brain function. Blood, 2022. 140(8): p. 815-827

    2022

  11. [19]

    Kim, and S

    Chaudhary, P.K., S. Kim, and S. Kim, An Insight into Recent Advances on Platelet Function in Health and Disease. Int J Mol Sci, 2022. 23(11)

    2022

  12. [20]

    Monroe, and H.R

    Hoffman, M., D.M. Monroe, and H.R. Roberts, A rapid method to isolate platelets from human blood by density gradient centrifugation. Am J Clin Pathol, 1992. 98(5): p. 531-3

    1992

  13. [21]

    Int J Lab Hematol, 2023

    Jin, J., et al., High-purity isolation platelets by gradient centrifugation plus filtration. Int J Lab Hematol, 2023. 45(2): p. 187-194

    2023

  14. [22]

    Biomedicines, 2021

    Vernerova, A., et al., Mitochondrial Respiration of Platelets: Comparison of Isolation Methods. Biomedicines, 2021. 9(12)

    2021

  15. [23]

    Selheim, and M

    Carrillo-Rodriguez, P., F. Selheim, and M. Hernandez-Valladares, Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps. Cancers (Basel), 2023. 15(2)

    2023

  16. [24]

    Front Mol Neurosci, 2020

    Li, K.W., et al., Recent Developments in Data Independent Acquisition (DIA) Mass Spectrometry: Application of Quantitative Analysis of the Brain Proteome. Front Mol Neurosci, 2020. 13: p. 564446

    2020

  17. [25]

    Nat Med, 2024

    Argentieri, M.A., et al., Proteomic aging clock predicts mortality and risk of common age- related diseases in diverse populations. Nat Med, 2024. 30(9): p. 2450-2460

    2024

  18. [26]

    Haematologica, 2023

    Sabrkhany, S., et al., Age- and gender-matched controls needed for platelet-based biomarker studies. Haematologica, 2023. 108(6): p. 1667-1670

    2023

  19. [27]

    Extending the limits of quantitative proteome profiling with data- independent acquisition

    Bruderer et al., 2015. Extending the limits of quantitative proteome profiling with data- independent acquisition. Mol. Cell. Proteomics, 14(5), 1400-1410. DOI: 10.1074/mcp.M114.044305

    2015 doi

  20. [28]

    exclude isotopes

    Rost et al., 2016. OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat. Biotechnol., 34(8), 828-837. DOI: 10.1038/nbt.3685 Figures/Tables: Figure 1: Schematic overview of the isolation of platelets process outlined in this protocol Figur...

    2016 doi

Pith tools

Reviewed August 7, 2026 · model on record in the stance chip above.